Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Catheter Precision (VTAK) Cost of Revenue (2017 - 2025)

Catheter Precision has reported Cost of Revenue over the past 9 years, most recently at $20000.0 for Q4 2025.

  • Quarterly Cost of Revenue rose 81.82% to $20000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $63000.0 through Dec 2025, up 50.0% year-over-year, with the annual reading at $63000.0 for FY2025, 50.0% up from the prior year.
  • Cost of Revenue was $20000.0 for Q4 2025 at Catheter Precision, up from $18000.0 in the prior quarter.
  • Over five years, Cost of Revenue peaked at $1.5 million in Q2 2021 and troughed at -$42000.0 in Q4 2022.
  • The 5-year median for Cost of Revenue is $14000.0 (2025), against an average of $146421.1.
  • Year-over-year, Cost of Revenue tumbled 112.1% in 2022 and then skyrocketed 128.57% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $347000.0 in 2021, then tumbled by 112.1% to -$42000.0 in 2022, then surged by 116.67% to $7000.0 in 2023, then soared by 57.14% to $11000.0 in 2024, then soared by 81.82% to $20000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Cost of Revenue are $20000.0 (Q4 2025), $18000.0 (Q3 2025), and $14000.0 (Q2 2025).